Immunotherapy has emerged as a breakthrough strategy in cancer treatment. mRNA
vaccines are an attractive and powerful immunotherapeutic platform against cancer because …

Traditional vaccines use inactivated or weakened forms of pathogens which could have side
effects and inadequate immune responses. To overcome these challenges, phage display …

The rapid development of the SARS-CoV-2 vaccine has been used to prevent the spread of
coronavirus 2019 (COVID-19). However, the ongoing and future pandemics caused by …

Abstract The International Society of RNA Nanotechnology and Nanomedicine (ISRNN)
serves to further the development of a wide variety of functional nucleic acids and other …

We introduce a toehold-mediated strand displacement strategy for regulated shape-
switching of nucleic acid nanoparticles (NANPs) enabling their sequential transformation …

The continuous emergence of novel SARS-CoV-2 variants and subvariants serves as
compelling evidence that COVID-19 is an ongoing concern. The swift, well-coordinated …

Transferases are ubiquitous across all known life. While much work has been done to
understand and describe these essential enzymes, there have been minimal efforts to exert …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues its global
spread, the exploration of novel therapeutic and diagnostic strategies is still needed. The …

Preventing immune escape of SARS-CoV-2 variants is crucial in vaccine development to
ensure broad protection against the virus. Conformational epitopes beyond the RBD region …

Traditional vaccines use inactivated or weakened forms of pathogens which could have side
effects and inadequate immune responses. To overcome these challenges, phage display …